Influence of autologous dendritic cells on the in-vitro expansion and functions of peripheral blood NK cells

References

• Childs RW, Berg M. Bringing natural killer cells to the clinic: ex vivo manipulation. Hematology Am Soc Hematol Educ Program 2013;2013:234–246
   PubMed Web of Science ®Google Scholar
• Miller JS. Therapeutic applications: natural killer cells in the clinic. Hematology Am Soc Hematol Educ Program 2013;2013:247–253
   PubMed Web of Science ®Google Scholar
• Della Chiesa M, Falco M, Muccio L, et al. Impact of HCMV infection on NK cell development and function after HSCT. Front Immunol 2013;4:458
   PubMed Web of Science ®Google Scholar
• Herberman RB, Nunn ME, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity. Int J Cancer 1975;16:216–229
   PubMed Web of Science ®Google Scholar
• van der Touw W, Burrell B, Lal G, Bromberg JS. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts. Transplantation 2012;94:575–584
   PubMed Web of Science ®Google Scholar
• Ruggeri L, Capanni M, Casucci M, et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999;94:333–339
   PubMed Web of Science ®Google Scholar
• Nguyen S, Dhedin N, Vernant JP, et al. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood 2005;105:4135–4142
   PubMed Web of Science ®Google Scholar
• Dong LJ. [KIR and allogeneic hematopoietic cell transplantation − review]. Zhongguo shi yan xue ye xue za zhi/Zhongguo bing li sheng li xue hui = Journal of Experimental Hematology/Chinese Association of Pathophysiology 2004;12:108–114
   PubMedGoogle Scholar
• Passweg JR, Stern M, Koehl U, et al. Use of natural killer cells in hematopoetic stem cell transplantation. Bone Marrow Transplant 2005;35:637–643
   PubMed Web of Science ®Google Scholar
• Li XH, Gao CJ. [Role of NK cells in allogeneic hematopoietic stem cell transplantation − review]. Zhongguo shi yan xue ye xue za zhi/Zhongguo bing li sheng li xue hui = Journal of Experimental Hematology/Chinese Association of Pathophysiology 2006;14:845–848
   PubMedGoogle Scholar
• Koepsell SA, Miller JS, McKenna Jr DH. Natural killer cells: a review of manufacturing and clinical utility. Transfusion 2013;53:404–410
   PubMed Web of Science ®Google Scholar
• Siegler U, Meyer-Monard S, Jorger S, et al. Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients. Cytotherapy 2010;12:750–763
   PubMed Web of Science ®Google Scholar
• Luhm J, Brand JM, Koritke P, et al. Large-scale generation of natural killer lymphocytes for clinical application. J Hematother Stem Cell Res 2002;11:651–657
   PubMedGoogle Scholar
• Fujisaki H, Kakuda H, Shimasaki N, et al. Expansion of highly cytotoxic human natural killer cells for cancer cell therapy. Cancer Res 2009;69:4010–4017
   PubMed Web of Science ®Google Scholar
• Peng BG, Liang LJ, He Q, et al. [Selective expansion of human natural killer cells]. Ai zheng = Aizheng = Chinese Journal of Cancer 2005;24:1287–1289
   PubMedGoogle Scholar
• Torelli GF, Guarini A, Maggio R, et al. Expansion of natural killer cells with lytic activity against autologous blasts from adult and pediatric acute lymphoid leukemia patients in complete hematologic remission. Haematologica 2005;90:785–792
   PubMed Web of Science ®Google Scholar
• Berg M, Lundqvist A, McCoy Jr P, et al. Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells. Cytotherapy 2009;11:341–355
   PubMed Web of Science ®Google Scholar
• Ferlazzo G, Tsang ML, Moretta L, et al. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002;195:343–351
   PubMed Web of Science ®Google Scholar
• Piccioli D, Sbrana S, Melandri E, Valiante NM. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 2002;195:335–341
   PubMed Web of Science ®Google Scholar
• Ferlazzo G, Pack M, Thomas D, et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 2004;101:16606–16611
   PubMed Web of Science ®Google Scholar
• Klingemann HG, Martinson J. Ex vivo expansion of natural killer cells for clinical applications. Cytotherapy 2004;6:15–22
   PubMed Web of Science ®Google Scholar
• Nguyen S, Beziat V, Norol F, et al. Infusion of allogeneic natural killer cells in a patient with acute myeloid leukemia in relapse after haploidentical hematopoietic stem cell transplantation. Transfusion 2011;51:1769–1778
   PubMed Web of Science ®Google Scholar
• Klingemann H, Grodman C, Cutler E, et al. Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions. Transfusion 2013;53:412–418; quiz 411
   PubMed Web of Science ®Google Scholar
• Barkholt L, Alici E, Conrad R, et al. Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study. Immunotherapy 2009;1:753–764
   PubMed Web of Science ®Google Scholar
• Koehl U, Esser R, Zimmermann S, et al. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children. Klin Padiatr 2005;217:345–350
   PubMed Web of Science ®Google Scholar
• de Rham C, Ferrari-Lacraz S, Jendly S, et al. The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors. Arthritis Res Ther 2007;9:R125
   PubMed Web of Science ®Google Scholar
• Mirandola P, Ponti C, Gobbi G, et al. The response of human natural killer cells to interleukin-2. J Endocrinol Invest 2004;27:146–150
   PubMedGoogle Scholar
• Lin SJ, Chao HC, Yan DC. Phenotypic changes of T-lymphocyte subsets induced by interleukin-12 and interleukin-15 in umbilical cord vs. adult peripheral blood mononuclear cells. Pediatr Allergy Immunol 2001;12:21–26
   PubMed Web of Science ®Google Scholar
• Li XH, Ma J, Wu XX, et al. [Study on ex vivo expansion of highly purified NK cells from human peripheral blood and changes in their function]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2009;30:404–408
   PubMedGoogle Scholar
• Chapuis F, Rosenzwajg M, Yagello M, et al. Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 1997;27:431–441
   PubMed Web of Science ®Google Scholar
• Bender A, Sapp M, Schuler G, et al. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 1996;196:121–135
   PubMed Web of Science ®Google Scholar
• Shresta S, MacIvor DM, Heusel JW, et al. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc Natl Acad Sci USA 1995;92:5679–5683
   PubMed Web of Science ®Google Scholar
• Lowin B, Beermann F, Schmidt A, Tschopp J. A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proc Natl Acad Sci USA 1994;91:11571–11575
   PubMed Web of Science ®Google Scholar
• Jinushi M, Takehara T, Kanto T, et al. Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C virus infection. J Immunol 2003;170:1249–1256
   PubMed Web of Science ®Google Scholar
• Vitale M, Della Chiesa M, Carlomagno S, et al. The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells. Eur J Immunol 2004;34:1715–1722
   PubMed Web of Science ®Google Scholar
• Yang YG, Wang H, Asavaroengchai W, Dey BR. Role of interferon-gamma in GVHD and GVL. Cell Mol Immunol 2005;2:323–329
   PubMed Web of Science ®Google Scholar
• Barriera da Silva R, Munz C. Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals. Cell Mol Life Sci 2011;68:3505–3518
   PubMed Web of Science ®Google Scholar